Estrogen response elements can mediate agonist activity of anti-estrogens in human endometrial Ishikawa cells

被引:40
|
作者
Barsalou, A [1 ]
Gao, WL [1 ]
Anghel, SI [1 ]
Carrière, J [1 ]
Mader, S [1 ]
机构
[1] Univ Montreal, Fac Med, Dept Biochim, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1074/jbc.273.27.17138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anti-estrogens like hydroxytamoxifen (OHT) have mixed agonist/antagonist activities, leading to tissue-specific stimulation of cellular proliferation. Partial agonist activity of OHT can be observed in vitro in endometrial carcinoma cells like Ishikawa. Here, we have compared several anti-estrogens (including extensively characterized OHT and pure anti-estrogens such as ICI164,384 and RU58,668, which are devoid of uterotrophic activity) for their capacity to stimulate promoters containing estrogen response elements (EREs) or AP1-binding sites (12-O-tetradecanoylphorbol-13-acetate response elements, TREs), the two types of DNA motifs known to mediate transcriptional stimulation by estrogen receptors. Assays were performed in Ishikawa cells either by transient transfection or by using cell lines with stably propagated reporter vectors. In transient transfection experiments, none of the anti-estrogens displayed agonist activity on the promoters tested. In contrast, significant transcriptional stimulation was observed with low concentrations of OHT and RU39,411 in Ishikawa cells stably propagating reporter constructs containing a minimal ERE3-TATA promoter. In addition, micromolar concentrations of OHT, but not of RU39,411, stimulated stably propagated AP1-responsive reporter constructs. No transcriptional stimulation of ERE- or TRE-containing promoters was observed with the pure anti-estrogens ICI164,384 and RU58,668. These results indicate that the presence of estrogen response elements in promoters is sufficient to mediate cell-specific agonism of anti-estrogens at the transcriptional level, and that stimulation of AP1 activity may be restricted to a subset of anti-estrogens possessing agonist activity on EREs. In addition, our results suggest that transient transfections do not fully recapitulate in vivo conditions required to observe agonist activity of anti-estrogens.
引用
收藏
页码:17138 / 17146
页数:9
相关论文
共 50 条
  • [21] Human Endometrial Endothelial Cells Generate an Inflammatory and Anti-Viral Response to a TLR3 Agonist
    Krikun, Graciela
    Potter, Julie
    Guller, Seth
    Mor, Gil
    Abrahams, Vikki M.
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 100A - 100A
  • [22] The genomic response of Ishikawa cells to chemicals with estrogenic activity supports their use as a potential alternative to animal testing for estrogens
    Naciff, J. M.
    Khambatta, Z. S.
    Carr, J. G.
    Thomason, R. G.
    Reichling, T. D.
    Tiesman, J. P.
    Daston, G. P.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2007, 79 (05) : 377 - 377
  • [23] Synergistic in vitro anti-tumor effect of letrozole and everolimus on human endometrial carcinoma Ishikawa cells
    Lu, X. -Y.
    Yang, Y.
    Xu, H.
    Zeng, T.
    Zhang, Z. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (16) : 2264 - 2269
  • [24] Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma
    Maillard, S
    Ameller, T
    Gauduchon, J
    Gougelet, A
    Gouilleux, F
    Legrand, P
    Marsaud, V
    Fattal, E
    Sola, B
    Renoir, JM
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 94 (1-3): : 111 - 121
  • [25] ROLE OF INSULIN IN MODIFYING THE RESPONSE OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7 TO ANTI-ESTROGENS
    BUTLER, WB
    KELSEY, WH
    GORAN, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 247 - 247
  • [26] CELL-CYCLE CONTROL OF HUMAN-BREAST CANCER-CELLS BY ANTI-ESTROGENS AND PROGESTINS - STUDIES OF THE MOLECULAR MECHANISMS
    JOZAN, S
    FAYE, JC
    BAYARD, F
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1981, 11 (02) : 16 - 16
  • [27] USE OF ANTI-ESTROGENS TAMOXIFEN AND NAFOXIDINE IN TREATMENT OF HUMAN BREAST-CANCER IN CORRELATION WITH ESTROGEN-RECEPTOR VALUES - PHASE-2 STUDY
    MOSESON, DL
    SASAKI, GH
    KRAYBILL, WG
    LEUNG, BS
    DAVENPORT, CE
    FLETCHER, WS
    CANCER, 1978, 41 (03) : 797 - 800
  • [28] Glyphosate induces epithelial mesenchymal transition-related changes in human endometrial Ishikawa cells via estrogen receptor pathway
    Gastiazoro, M. P.
    Durando, M.
    Milesi, M. M.
    Lorenz, V
    Vollmer, G.
    Varayoud, J.
    Zierau, O.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2020, 510
  • [29] PCAF acetylates HOXA10 and regulates its transcriptional activity in both Ishikawa cells and human endometrial stromal cells
    Zhu, L.
    Jiang, Y. U. E.
    Chen, J. I. N. G.
    Shen, X.
    Liu, H.
    Wang, B. I. N.
    Yan, G.
    Sun, H.
    HUMAN REPRODUCTION, 2012, 27
  • [30] The Src kinase pathway promotes tamoxifen agonist action in ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor α promoter interaction and elevated steroid receptor coactivator 1 activity
    Shah, YM
    Rowan, BG
    MOLECULAR ENDOCRINOLOGY, 2005, 19 (03) : 732 - 748